Clinical Trial Update: A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating belantamab mafodotin in relapsed or refractory AL amyloidosis has completed. The trial was conducted under the Stichting European Myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• Belantamab Mafodotin (belantamab mafodotin)

Snippet

Sponsor: Stichting European Myeloma Network | Conditions: AL Amyloidosis | Phase 2 | Status: COMPLETED